Skip to main content
. 2015 Jan 22;11(2):421–427. doi: 10.4161/21645515.2014.988549

Table 2.

Vaccine samples used in this study*

No. Vaccine types Indicated pertussis component content per single human dose
S1 DTwP 4.5 × 109 CFU of B. pertussis
S2 Co-purified DTaP 9 PNμg of pertussis antigens
S3 Co-purified DTaP 9 PNμg of pertussis antigens
S4 purified DTaP PT 25 μg, FHA 25 μg, PRN 8 μg

*Note: DTwP, diphtheria, tetanus and whole cell pertussis vaccines; DTaP, diphtheria, tetanus toxoids and acellular pertussis vaccines.